Grifols (GRFS) Net Debt Issuances and Repayments (2017 - 2020)

Grifols (GRFS) posted Net Debt Issuances and Repayments of -$130.2 million for Q1 2020, up 59.92% quarter-over-quarter from -$324.9 million in Q4 2019, and up 75.96% year-on-year from -$74.0 million in Q2 2019.

Grifols (GRFS) Net Debt Issuances and Repayments (2017 - 2020) Analysis & Trends

Grifols (GRFS) has reported Net Debt Issuances and Repayments for 4 consecutive years, with -$130.2 million the latest figure, recorded in Q1 2020.

  • Net Debt Issuances and Repayments for Q1 2020 came in at -$130.2 million, up 75.96% year-over-year; the trailing twelve-month figure through Mar 2020 was -$615.9 million (down 368.98% YoY), and the FY2019 annual result was -$324.9 million, down 185.27% from the prior year.
  • Net Debt Issuances and Repayments was -$130.2 million for Q1 2020 at Grifols, up from -$324.9 million in the prior quarter.
  • Over five years, Net Debt Issuances and Repayments peaked at $381.1 million in Q4 2018 and troughed at -$541.8 million in Q1 2019.
  • Average Net Debt Issuances and Repayments over 4 years is -$61.4 million, with a median of $8.0 million recorded in 2017.
  • Year-over-year, Net Debt Issuances and Repayments surged 4662.07% in 2018 and slumped 2629.63% in 2019.
  • Over 4 years, Net Debt Issuances and Repayments stood at $8.0 million in 2017, then soared by 4662.07% to $381.1 million in 2018, then tumbled by 185.27% to -$324.9 million in 2019, then jumped by 59.92% to -$130.2 million in 2020.
  • Per Business Quant data, the three most recent Net Debt Issuances and Repayments figures were -$130.2 million in Q1 2020, -$324.9 million in Q4 2019, and -$541.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 1.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -130.24 Mn
Mar 31, 2020 -130.24 Mn
Dec 31, 2019 -324.92 Mn
Dec 31, 2019 -324.92 Mn
Mar 31, 2019 -541.80 Mn
Mar 31, 2019 -541.80 Mn
Dec 31, 2018 381.05 Mn
Dec 31, 2018 381.05 Mn
Mar 31, 2018 21.42 Mn
Mar 31, 2018 21.42 Mn
Dec 31, 2017 8.00 Mn
Dec 31, 2017 8.00 Mn
Mar 31, 2017 156.72 Mn
Mar 31, 2017 156.72 Mn